StockNote
NHD
Nam Ha Pharmaceutical Joint Stock Company (NHD), formerly known as Ich Hoa Sinh Pharmaceutical Factory, was established in 1960. The company operates mainly in the field of manufacturing, trading and import and export of pharmaceutical products, health foods, cosmetics, medicinal materials, chemicals and medical equipment. NHD currently owns a wide distribution network across 34 provinces/ cities with 6 large branches in Hanoi, Ninh Binh, Nghe An, Da Nang, Hoi Chi Minh City, Can Tho and a system of more than 20,000 pharmacies nationwide. Nam Ha Pharmaceutical branded products have been available in many countries such as Russia, Laos, Cambodia, Bangladesh, Myanmar and many African countries. On June 5, 2026, NHD officially traded on UPCOM market.
NHD currently has a market capitalization of roughly VND 369 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 10,3x is 0% above its own 1-year average (10,3x), suggesting the stock is trading richer than its historical norm. P/B stands at 1,2x, 0% above its multi-year average of 1,2x. Return on equity (ROE) is at 12,2%, up from 8,9% the year before. In 2025, revenue grew 6% year-on-year while after-tax profit grew 50%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Revenue & Profit
Unit: VND billion. Growth (%) vs. previous period.
Not enough data for this period.
Market Cap
Unit: VND billion. Year-end values; current year uses latest session.
Not enough data.
Debt / Equity
Unit: x. Financial debt over shareholders' equity.
Not applicable for this sector (banking/finance) or data unavailable.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.